JP2023550600A5 - - Google Patents

Info

Publication number
JP2023550600A5
JP2023550600A5 JP2023526888A JP2023526888A JP2023550600A5 JP 2023550600 A5 JP2023550600 A5 JP 2023550600A5 JP 2023526888 A JP2023526888 A JP 2023526888A JP 2023526888 A JP2023526888 A JP 2023526888A JP 2023550600 A5 JP2023550600 A5 JP 2023550600A5
Authority
JP
Japan
Prior art keywords
composition according
antigen
influenza
mrna
mrna molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023526888A
Other languages
English (en)
Japanese (ja)
Other versions
JP7817257B2 (ja
JP2023550600A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/058250 external-priority patent/WO2022099003A1/en
Publication of JP2023550600A publication Critical patent/JP2023550600A/ja
Publication of JP2023550600A5 publication Critical patent/JP2023550600A5/ja
Priority to JP2026017400A priority Critical patent/JP2026089059A/ja
Application granted granted Critical
Publication of JP7817257B2 publication Critical patent/JP7817257B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023526888A 2020-11-06 2021-11-05 ｍＲＮＡワクチンを送達するための脂質ナノ粒子 Active JP7817257B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026017400A JP2026089059A (ja) 2020-11-06 2026-02-05 ｍＲＮＡワクチンを送達するための脂質ナノ粒子

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063110965P 2020-11-06 2020-11-06
US63/110,965 2020-11-06
US202163212523P 2021-06-18 2021-06-18
US63/212,523 2021-06-18
EP21315198.8 2021-10-13
EP21315198 2021-10-13
PCT/US2021/058250 WO2022099003A1 (en) 2020-11-06 2021-11-05 Lipid nanoparticles for delivering mrna vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026017400A Division JP2026089059A (ja) 2020-11-06 2026-02-05 ｍＲＮＡワクチンを送達するための脂質ナノ粒子

Publications (3)

Publication Number Publication Date
JP2023550600A JP2023550600A (ja) 2023-12-04
JP2023550600A5 true JP2023550600A5 (enExample) 2025-06-17
JP7817257B2 JP7817257B2 (ja) 2026-02-18

Family

ID=86184333

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023526888A Active JP7817257B2 (ja) 2020-11-06 2021-11-05 ｍＲＮＡワクチンを送達するための脂質ナノ粒子
JP2026017400A Pending JP2026089059A (ja) 2020-11-06 2026-02-05 ｍＲＮＡワクチンを送達するための脂質ナノ粒子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026017400A Pending JP2026089059A (ja) 2020-11-06 2026-02-05 ｍＲＮＡワクチンを送達するための脂質ナノ粒子

Country Status (9)

Country Link
EP (1) EP4240335A1 (enExample)
JP (2) JP7817257B2 (enExample)
KR (1) KR20230104223A (enExample)
CN (1) CN116406299A (enExample)
AU (1) AU2021374976A1 (enExample)
CA (1) CA3194325A1 (enExample)
CO (1) CO2023005218A2 (enExample)
IL (1) IL302631A (enExample)
MX (1) MX2023005203A (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3328394A4 (en) 2015-07-30 2019-03-13 ModernaTX, Inc. CONCATEMEE peptide epitope RNAs
DE20164728T1 (de) 2015-10-22 2021-09-30 Modernatx, Inc. Impfstoffe gegen atemwegsvirus
US11911453B2 (en) 2018-01-29 2024-02-27 Modernatx, Inc. RSV RNA vaccines
AU2022294274A1 (en) * 2021-06-18 2024-02-01 Sanofi Pasteur Inc. Multivalent influenza vaccines
US20260176618A1 (en) * 2022-11-03 2026-06-25 Modernatx, Inc. Chemical stability of mrna
CN118021957A (zh) * 2022-11-11 2024-05-14 深圳先进技术研究院 一种编码抗禽流感H7N9病毒抗体的mRNA及其制法和应用
CN118021956A (zh) * 2022-11-11 2024-05-14 深圳先进技术研究院 一种编码抗禽流感H7N9病毒抗体的mRNA及其制法和应用
WO2025054383A1 (en) * 2023-09-06 2025-03-13 Modernatx, Inc. Chemical stability of mrna
CN122422511A (zh) * 2023-10-31 2026-07-17 仁景(苏州)生物科技有限公司 一种多价流感mRNA疫苗
CN120053395A (zh) * 2023-11-30 2025-05-30 苏州维益生物科技有限公司 含二硫键的核酸-脂质颗粒、药物、用途、及制备方法
CN118725043B (zh) * 2024-06-27 2025-12-05 中国人民解放军陆军军医大学 用于递送核酸的多肽-脂质组合物及其应用和mRNA疫苗
CN121265551A (zh) * 2024-07-02 2026-01-06 苏州星核迪赛生物技术有限公司 一种靶向肝实质细胞的核酸递送载体及其应用
WO2026095067A1 (ja) * 2024-11-01 2026-05-07 Ａｇｃ株式会社 核酸送達用脂質ナノ粒子
CN119746089B (zh) * 2025-03-07 2025-06-13 细胞生态海河实验室 脂质纳米颗粒冷冻保护剂
CN121466311A (zh) * 2026-01-09 2026-02-06 羿美诚健(上海)生物医药有限公司 一种脂质组合物及其在核酸递送中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3122878T3 (pl) * 2014-03-24 2019-06-28 Translate Bio, Inc. TERAPIA mRNA DO LECZENIA CHORÓB OCZU
RS64331B1 (sr) * 2015-06-19 2023-08-31 Massachusetts Inst Technology Alkenil supstituisani 2,5-piperazindioni i njihova primena u sastavima za isporuku agensa u organizam ili ćeliju subjekta
TW202309002A (zh) * 2021-04-15 2023-03-01 美商轉譯生技公司 基於「古德」緩衝液的陽離子脂質

Similar Documents

Publication Publication Date Title
JP2024528418A5 (enExample)
US12239735B2 (en) Lipid nanoparticles for delivering mRNA vaccines
JP7817257B2 (ja) ｍＲＮＡワクチンを送達するための脂質ナノ粒子
JP2023530229A5 (enExample)
ES2731899T3 (es) Composición de vacuna nasal contra la gripe
US20230043128A1 (en) Multivalent influenza vaccines
JP2023550666A5 (enExample)
IL321503A (en) Recombinant virus, composition comprising the same, and uses thereof
US20240156966A1 (en) A sirna drug, a pharmaceutical composition, a sirna-small molecule drug conjugate, and the application thereof
US20190314486A1 (en) Influenza hemagglutinin protein vaccines
US11878055B1 (en) Coronavirus vaccine
IL304032A (en) Coronavirus vaccine
US9060972B2 (en) Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
Ftouh et al. Contribution of nanotechnologies to vaccine development and drug delivery against respiratory viruses
CN121419787A (zh) 多价流感mRNA疫苗
RU2023114690A (ru) ЛИПИДНЫЕ НАНОЧАСТИЦЫ ДЛЯ ДОСТАВКИ mRNA-ВАКЦИНA
RU2024101100A (ru) Поливалентные вакцины против гриппа
TW202508620A (zh) 呼吸道mrna組合疫苗
CN117580568A (zh) 多价流感疫苗
RU2860421C2 (ru) ЛИПИДНЫЕ НАНОЧАСТИЦЫ ДЛЯ ДОСТАВКИ mRNA-ВАКЦИНЫ
JPWO2022244825A5 (enExample)
HK40096671A (en) Lipid nanoparticles for delivering mrna vaccines
JP2025536956A (ja) 目的遺伝子ｒｎａ製剤
TW202610663A (zh) 多價抗原
RU2025121933A (ru) Нуклеиновые кислоты и их применение